Добавил:
mguppmed@mgupp.ru Медицинский институт непрерывного образования ФГБОУ ВО “Российский биотехнологический университет (РОСБИОТЕХ)” https://mgupp.ru/about/ 125080, Россия, Москва Волоколамское шоссе, д.11. mguppmed@mgupp.ru, +7 (495) 2083443 или +7 (926) 0044629 или +74997500111,7200 +74997500111,7123 http://www.mgupp.ru директор +74997500111,6897 Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Микозы / Соколова 2015 Рубромикоз крупных складок Аннотация

.pdf
Скачиваний:
29
Добавлен:
17.03.2019
Размер:
74.13 Кб
Скачать

Рубромикоз крупных складок у амбулаторных больных: особенности течения и оптимизация терапии

Source: Klinicheskaya Dermatologia I Venerologia . 2015, Vol. 14 Issue 6, p87-97. 11p.

Author(s): ГАЗАРЯН, О. Л.; СОКОЛОВА, Т. В.; МАЛЯРЧУК, А. П.; ГЛАДЬКО, В. В.

Abstract:

We studied the incidence of rubromycosis of large folds in outpatients, analyzed the characteristic features of the course, justified the criteria of the differential diagnosis of rubromycosis and epidermophytia of large folds, and assessed the efficacy of sertaconazole (Zalain). Material and methods. The work was carried out as the part of a multicenter study (2012—2013) conducted in 50 regions of the Russian Federation. Results. Rubromycosis of large folds is characterized by more aggressive course compared to epidermophytia. The process more often involves two or more large folds (1.6 times), including intergluteal fold (2.6 times). Foot and toenails are most commonly involved (1.6 and 2.7 times, respectively), often with multiple onychomycosis (2.8±0.4), which if mostly hypertrophic. There is also hand mycosis (20%) with onychomycosis (17.1%) and lesions at other areas of the skin (51.4%). Mycotic eczema is the most common complication (1.7 times). Sertaconazole (Zalain) is an effective drug to treat rubromycosis of large folds, particularly in combination with athlete’s foot, onychomycosis with SCIO index of 1—2, and involvement of other areas of the skin. Conclusions. The rate of resolution of clinical manifestations in patients with rubromycosis of large folds correlates with the age of patients (older then 35 years), disease duration (more than 2 months), the presence of concomitant somatic pathology, the number of folds involved in the process, the presence of athlete’s foot and onychomycosis, the presence of complications of the underlying disease (secondary pyoderma, mycotic eczema), and the history of using various topical antimycotics. These factors determine the contingent of patients who need the maximum period of treatment of 1 month.

(Russian). (English) Copyright of Klinicheskaya Dermatologia I Venerologia is the property of Media Sphere Publishing Group and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.

open in browser

PRO version

Are you a developer? Try out the HTML to PDF API

pdfcrowd.com

For access to this entire article and additional high quality information, please check with your college/university library, local public library, or affiliated institution.

Important User Information: Remote access to EBSCO's databases is permitted to patrons of subscribing institutions accessing from remote locations for personal, non-commercial use. However, remote access to EBSCO's databases from non-subscribing institutions is not allowed if the purpose of the use is for commercial gain through cost reduction or avoidance for a non-subscribing institution.

Privacy Policy

Terms of Use

Copyright

© 2017 EBSCO Industries, Inc. All rights reserved.

open in browser

PRO version

Are you a developer? Try out the HTML to PDF API

pdfcrowd.com

Соседние файлы в папке Микозы